| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 40.2506 | 7 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.9047 | 36 |
| GSM780709 | Untreated after 4 days (C3_1) | 39.4716 | 5 |
| GSM780719 | Untreated after 4 days (C1_2) | 47.1002 | 37 |
| GSM780720 | Untreated after 4 days (C2_2) | 54.4249 | 59 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.98 | 22 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 53.1291 | 56 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 53.357 | 57 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.6475 | 25 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.6312 | 40 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.5725 | 25 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.0631 | 37 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 40.4221 | 8 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.0896 | 18 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 43.5929 | 20 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 45.8161 | 31 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 50.3521 | 50 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 46.3462 | 34 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 82.837 | 72 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 69.2446 | 69 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.2265 | 38 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 64.0847 | 67 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 61.0509 | 65 |